1224948-48-4

Upstream product

• 1224949-55-6 8-(1-(4-chlorophenyl)-5-(p-tolyl)-1H-pyrazol-3-yl)-1,4-dioxaspiro[4.5]decan-8-ol 
• 1224949-36-3 3-(8-hydroxy-1,4-dioxaspiro[4.5]decan-8-yl)-1-(p-tolyl)-2-propyn-1-one 
• 1224949-24-9 8-(3-hydroxy-3-(p-tolyl)propyn-1-yl)-1,4-dioxaspiro[4.5]decan-8-ol 
• 320342-34-5 8-[(trimethylsilyl)ethynyl]-1,4-dioxaspiro[4.5]decan-8-ol 
• 4746-97-8 cyclohexanedione monoethylene ketal 
• 70097-74-4 8-ethynyl-1,4-dioxaspiro[4.5]decan-8-ol 

Downstream Products

• 1224948-13-3 1-(1-(4-chlorophenyl)-5-(p-tolyl)-1H-pyrazol-3-yl)cyclohexan-cis-1,4-diol 
• 1224948-12-2 1-(1-(4-chlorophenyl)-5-(p-tolyl)-1H-pyrazol-3-yl)cyclohexan-trans-1,4-diol 

Relevant academic research and scientific papers

THERAPEUTIC AGENT OR PROPHYLACTIC AGENT FOR FIBROMYALGIA

An object of the present invention is to provide a therapeutic agent or prophylactic agent which has an analgesic effect on both nociceptive pain and neuropathic pain and is effective in treatment of fibromyalgia. The present invention provides a therapeutic agent or prophylactic agent for fibromyalgia, said agent comprising as an effective ingredient a cyclohexane derivative exemplified by the formula below, or a pharmaceutically acceptable salt thereof or a prodrug thereof.

THERAPEUTIC AGENT AND PREVENTATIVE AGENT FOR ALZHEIMER'S DISEASE

An object of the present invention is to provide a therapeutic agent or prophylactic agent for Alzheimer's disease, which has an effect to inhibit or delay the progress of Alzheimer's disease and exhibits a long-lasting therapeutic effect on Alzheimer's disease even when used for a long period of time. The present invention provides a therapeutic agent or prophylactic agent for Alzheimer's disease, said agent comprising as an effective ingredient a cyclohexane derivative exemplified by the formula below, or a pharmaceutically acceptable salt thereof or a prodrug thereof.